UnitedHealth Group has remained a subject of active institutional attention through mid-2026. The company operates across managed care, pharmacy benefits, and health services segments, and has drawn continued scrutiny amid a broader environment of elevated healthcare costs and ongoing regulatory developments. Multiple briefings across June and early July 2026 noted this sustained institutional focus, reflecting the scale and complexity of UNH's operations across its diversified health services platform [Brief - 2026-07-03] [Brief - 2026-06-25] [Brief - 2026-06-17].
For the trailing twelve months ended 31 March 2026, UnitedHealth Group reported revenue of approximately $449.7 billion, representing year-over-year growth of 1.96%. Net income over the same period stood at $12.8 billion, with a net margin of 2.85% and an operating margin of 4.19%. Earnings per share grew 0.73% year-over-year. The company held $28.0 billion in cash against total debt of $77.9 billion. The price-to-earnings ratio was recorded at 31.97, with a market capitalisation of approximately $385.6 billion [SEC 10-Q - UNH - 2026-03-31].
Insider activity in July 2026 comprised 24 transactions with a mixed net direction and a net value of zero, indicating no dominant disposition or acquisition trend among insiders during the period [SEC Form 4 - UNH - 2026-07]. Institutional ownership shifts were material and divergent. Millennium Management added 56% to its UNH position, while AQR Capital increased its holding by 36% and Soros Fund Management added 14%. Conversely, Citadel reduced its position by 19% and Tiger Global trimmed its holding by 17%. These opposing adjustments across major funds constitute the primary trigger for this report [SEC 13F - Citadel - Q2 2026] [SEC 13F - Millennium - Q2 2026] [SEC 13F - AQR Capital - Q2 2026] [SEC 13F - Tiger Global - Q2 2026] [SEC 13F - Soros Fund Mgmt - Q2 2026].
The prevailing macroeconomic backdrop shows the 10-year US Treasury yield at 4.54% and the 2-year yield at 4.16%, producing a normal yield curve spread of 38 basis points [FRED DGS10] [FRED DGS2]. This interest rate environment is relevant context for a company carrying $77.9 billion in total debt and operating with relatively thin net margins across its high-revenue managed care and health services businesses.